Navigation Links
Osteotech Reports First Quarter 2009 Financial Results
Date:4/30/2009

$(.10) $.05 Shares used in computing earnings (loss) per share: Basic 17,874,236 17,716,902 Diluted 17,874,236 17,906,646 CONSOLIDATED SEGMENT REVENUE DETAIL (dollars in thousands) Three Months Ended March 31, 2009 2008 DBM $14,026 $16,966 Hybrid/Synthetic 748 644 Traditional Tissue 5,277 5,110 Spinal Allografts 1,880 2,250 Client Services 1,633 2,424 Other Product Lines 367 237 Revenue $23,931 $27,631 CONDENSED CONSOLIDATED BALANCE SHEETS (dollars in thousands) March 31, December 31, 2009 2008 Assets Cash and cash equivalents $13,697 $18,823 Accounts receivable, net 20,815 17,968 Deferred processing costs 42,689 38,715 Inventories 1,970 1,467 Other current assets 2,051 3,115 Total current assets 81,222 80,088 Property, plant and equipment, net 33,128 34,005 Other assets
'/>"/>
SOURCE Osteotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
7. Osteotech to Present at the Sidoti Conference in New York
8. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
9. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
10. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
11. Osteotechs Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... their offering. The markets for gene therapy ... approved gene therapy product and it is marketed in ... markets are estimated for the years 2014-2024. The estimates ...
(Date:9/2/2015)... ... September 02, 2015 , ... Drug companies ... compounds. BCC Research reveals in its new report that the U.S. will ... the category and generates the most market demand. , BCC Research examines ...
(Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
(Date:9/2/2015)... Israel , September 2, 2015 ... announced the intent of the National Institute of Allergy and ... Health (NIH) within the Department of Health and Human Services ... held in the United States in ... BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as a primer ...
Breaking Biology Technology:Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... (Nasdaq: NXTM ), a leading manufacturer of innovative ... Officer,will participate in the 19th Annual Piper Jaffray Healthcare ... the Company at 2:30 p.m.,Eastern Time on Tuesday, November ... To listen to the audio web cast of ...
... Third quarter Consolidated Net Income NIS 178 Million, Compared ... Adversely Affected by,Northern Hostilities - Company Publishing Today ... the Financing of the Strategic Plan; Debentures,Were Rated AA ... Oil Refineries Ltd. (TASE: ORL) ("Oil Refineries" or the ...
... (NYSE: BEC ), a leading developer, manufacturer, ... complex biomedical testing,announced today that Robert Raynor, Beckman ... 19th Annual Piper Jaffray Healthcare,Conference on Wednesday, November ... http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) The live webcast of ...
Cached Biology Technology:NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 3Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 4Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 5Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 6Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 7Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 8Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 9Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 10Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 11Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference 2
(Date:9/2/2015)... 2, 2015 Security of data and ... banks, government organizations, telecommunications, hospitals, as well as ... previously being used to prevent unauthorised access. Technological ... wherein individuals could gain access to secure premises ... as hardware devices and numeric codes. However, hackers ...
(Date:9/1/2015)... , Sept. 1, 2015  Automation and ... during airport passenger screening. This is the first ... screening process will become unintrusive. An assortment of ... on voluntary background investigations will transform the passenger ... & Sullivan, Global Airport Passenger Screening Market ...
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 Research ... of the "Saudi Arabia Biomedical Sensors Market - ... offering. The Saudi Arabia Biomedical Sensors ... a CAGR of 3.64% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
Breaking Biology News(10 mins):Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2
... after the United Nations called for a Green Revolution ... the promise of fighting hunger in Africa through agricultural ... and policies in the continent during the symposium, The ... from 1:15 to 3:45 pm in room R02 of ...
... in German . , Fossil remains of ... about their cognitive skills or give us details of ... team at the Max Planck Institute for Evolutionary Anthropology ... they have made some new and astonishing discoveries. Just ...
... of HIV often underlies the failure of current antiretroviral ... HIV genome confer resistance to individual drugs. Recombination, ... can accelerate the accumulation of resistance mutations by mixing ... failure of therapy. The dynamics of the emergence ...
Cached Biology News:Now is Africa's turn for a green revolution, global experts say 2Red hair and freckles... 2
... The versatile ST-195 allows real-time observations ... conditions. This instrument has 64 different strain ... CO2 incubator. The thin silicon strain chamber ... inverted microscopes and fluorescence microscopy. ST-195 can ...
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... Kit is used in conjunction with the EasyCount ... automatically. The ViaSure Staining Reagent uses a ... Orange and Ethidium Bromide to identify live and ... the EasyCount Slide 6 Multi-well Slide provides ...
... Bioconjugation Kit provides a powerful yet simple ... nuceleic acids. The kit provides the heterobifunctional ... for quantifying conjugation efficiencies. It enables conjugation ... and other tags with a variety of ...
Biology Products: